A Food Effect Study of LP-168 Tablets in Healthy Subjects

NCT05917964 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: LP-168 tablet

Sponsor

Guangzhou Lupeng Pharmaceutical Company LTD.